Noticias

¿Cuál es la evidencia científica de la eficacia de la ozonoterapia para tratar el coronavirus?

El nuevo síndrome respiratorio agudo severo (COVID-19) producido por un nuevo coronavirus, el SarsCoV2, se ha venido propagando desde el pasado mes de diciembre, alcanzando el estado de pandemia.

A día de hoy (27 de marzo de 2020) se ha confirmado en un total de 465.915 pacientes en todo el mundo. En Europa afecta a 277.297 personas, y en España se han diagnosticado un total de 65.719 casos.

Las tasas de mortalidad están en torno al 3,7%2 y actualmente no hay tratamiento eficaz.

Desde el punto de vista clínico los pacientes graves padecen un síndrome caracterizado por un crecimiento exagerado y una hiperactivación de determinadas células del sistema inmune (histiocitos).

Se produce una tormenta de citoquinas que son sustancias que se vuelven tóxicas contra las células de la sangre, a las que destruyen.

La destrucción de los glóbulos rojos hará que aumente en sangre la ferritina, que se encarga de captar el hierro que éstos llevaban en su interior.

Una fase final de “hiperinflamación” puede llevar a la muerte de algunos individuo.

Eficacia del ozono médico contra los virus

El ozono médico es uno de los mayores germicidas de la naturaleza, y ha demostrado su eficacia contra varios tipos de virus, como el bacteriófago MS2, el virus de Norwalk, el poliovirus 1, el virus de la hepatitis A y el Coxackievirus.

La exposición al ozono médico como protector y reparador del daño orgánico ha demostrado ser eficaz en investigaciones donde se ha visto su potencial para proteger los tejidos hepático, renal, cardíaco, pulmonar, pancreático, muscular, esquelético, intestinal y cerebral.

Esta propiedad demostrada en investigaciones preclínicas se ha constatado en el tratamiento complementario de muchas enfermedades, entre las que tienen interés especial la enfermedad pulmonar obstructiva crónica, el asma bronquial y el enfisema pulmonar.

Con respecto a las afecciones víricas, se han publicado trabajos en herpes virus (simplex y zoster),41-54 virus del SIDA (VIH) 55-60 y hepatitis (B y C).

Además, es de destacar la seguridad que aporta la ozonoterapia bien aplicada.

Según los diferentes test toxicológicos preclínicos siguiendo las normativas de la Food and Drug Administration estadounidense (FDA), de la Organización Mundial de la Salud, y de la Agencia Reguladora Cubana, el ozono médico solamente es nocivo por vía inhalatoria.

Tras cientos de aplicaciones en ensayos clínicos controlados, y en diferentes enfermedades, no se han detectado efectos adversos significativos.

La ozonoterapia mejora el sistema inmunitario

Estos hechos, además de que la ozonoterapia ha demostrado ser capaz de modular el sistema inmunitario, mejorando las defensas de los enfermos, dan pie a hipotetizar que la ozonoterapia podría ser eficaz para tratar el COVID-19.

Realmente, ahora mismo NO HAY NINGUNA EVIDENCIA CIENTÍFICA QUE AVALE QUE LA OZONOTERAPIA SEA EFICAZ PARA TRATAR EL COVID-19, aunque sí es una hipótesis a desarrollar con investigación seria y ensayos clínicos bien diseñados.La Federación Mundial de Ozonoterapia (WFOT) ya ha hecho una propuesta de ensayo clínico, y es público que varios ensayos se están llevando a cabo, o han sido propuestos y aceptados, en China e Italia.

Propuesta de la UCAM y SEOT a las autoridades sanitarias

En España, la Catedra de Ozonoterapia y Dolor Crónico de la Universidad Católica San Antonio de Murcia (UCAM), en conjunción con la Sociedad Española de Ozonoterapia (SEOT), han puesto en marcha una propuesta formal, con un diseño adecuado para valorar la eficacia y tolerabilidad de la ozonoterapia sistémica a la hora de tratar a estos pacientes.

Este proyecto se pondrá en conocimiento de las autoridades sanitarias pertinentes.

Fuente original:

www. clinalgia.com

REFERENCIAS

1. https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/situacionActual.htm. 2. Coronavirus disease 2019 (COVID-19) situation report – 52. March 12, 2020. https://www.who.int/docs/default-source/ coronaviruse/20200312-sitrep-52-covid-19. pdf?sfvrsn=e2bfc9c0_2 (accessed March 13, 2020). 3. Mehta P,McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. 2020 Mar 16. pii: S0140-6736(20)30628-0. 4. Kekez M.M., Sattar S.A. A new ozone-based method for virus inactivation: preliminary study. Phys Med Biol. 1997; 42: 2027-2039. 5. Shin G.A., Sobsey M.D. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water. Appl. Environ. Microbiol. 2003; 69: 3975-3978. 6. Herbold, K., Flehmig, B., Botzenhart, K. Appl Environ Microbiol. Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl. Environ. Microbiol. 1989; 55: 2949-2953. 7. Emerson, M.A., Sproul, O.J., Buck, C.E. Ozone inactivation of cell-associated viruses. Appl Environ Microbiol. 1982; 43: 603-608. 8. Peralta C, Xaus C, Bartrons R, León OS, Gelpi E, Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Rad Res 2000; 33:595-605. 9. Ajamieh HH, Menéndez S, Martínez-Sánchez G, Candelario-Jalil E, Re L, Giuliani A, Fernández OS. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int.2004; 24:55-62. 10. Ajamieh HH, Berlanga J, Merino N, Sánchez GM, Carmona AM, Cepero SM, Giuliani A, Re L, León OS. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int.2005; 18:604-612. 11. León OS, Ajamieh HH, Berlanga J, Menéndez S, Viebahn-Hánsler R, Re L, Carmona AM. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion. Transplant Int. 2008; 21:39–48. 12. Ajamieh H, Merino N, Candelario-Jalil E, Menéndez S, Martinez-Sanchez G, Re L, Giuliani A, Leon OS. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res.2002; 45:333-339. 13. Gultekin FA, Cakmak GK, Turkcu UO, Yurdakan G, Demir FE, Comert M. Effects of ozone oxidative preconditioning on liver regeneration after partial hepatectomy in rats. J Invest Surg.2013; 26:242-252. 14. Candelario-Jalil E, Mohammed-Al-Dalain S, Fernández OS, Menéndez S, Pérez-Davison G, Merino N, Sam S, Ajamieh HH. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol.2001; 21:297-301. 15. Aslaner A, Çakır T, Çelik B, Doğan U, Akyüz C, Baştürk A, Polat C, Gündüz U, Mayir B, Şehirli The protective effect of intraperitoneal medical ozone preconditioning and treatment on hepatotoxicity induced by methotrexate. Int J Clin Exp Med. 2015 ; 8: 13303–13309. 16. Sun W, Pei L. Ozone preconditioning and exposure to ketamine attenuates hepatic inflammation in septic rats. Arch Med Sci 2012; 8: 918-923. 17. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. J Surg Res.2008; 149: 287-295. 18. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol2008; 581:306-314. 19. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res2008; 39:169-178. 20. Wang L, Chen H, Liu XH, Chen ZY, Weng XD, Qiu T, Liu L. The protective effect of ozone oxidative preconditioning against hypoxia/reoxygenation injury in rat kidney cells. Ren Fail2014; 36:1449-1454. 21. Barber E, Menéndez S, León OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm.1999; 8:37-41. 22. Wang L, Chen H, Liu XH, Chen ZY, Weng XD, Qiu T, Liu L, Zhu H Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats. Exp Ther Med2014; 8:1764-1768. 23. Xing B, Chen H, Wang L, Weng X, Chen Z, Li X. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury via modulation of the TLR4-NF-κB pathway. Acta Cir Bras2015; 30:60-66. 24. Kurtoglu T, Durmaz S, Akgullu C, Gungor H, Eryilmaz U, Meteoglu I, Karul A, Boga M. Ozone preconditioning attenuates contrast-induced nephropathy in rats. J Surg Res2015; 195:604-611. 25. Ozonoterapia en la glomerulonefritis tóxica experimental por adriamicina. Calunga-Fernández JL, Bello-Ferro M, Chaple la Hoz M, Barber Gutiérrez E, Menéndez-Cepero S, Merino N. Rev Cubana Invest Biomed 2004; 23:139-143. 26. Calunga JL, Zamora ZB, Borrego A, Río Sd, Barber E, Menéndez S, Hernández F, Montero T, Taboada D. Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system. Mediators Inflamm2005; 2005: 221-227. 27. Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Morsy MD, Hassan WN, Zalat SI. Diabetol Metab Syndr2010; 2:29. 28. Aslaner A, Çakır T, Çelik B, Doğan U, Mayir B, Akyüz C, Polat C, Baştürk A, Soyer V, Koç S, Şehirli AÖ. Does intraperitoneal medical ozone preconditioning and treatment ameliorate the methotrexate induced nephrotoxicity in rats? Int J Clin Exp Med.2015; 8:13811-13817. 29. Delgado-Roche L, Hernández-Matos Y, Medina EA, Morejón DÁ, González MR, Martínez-Sánchez G. Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats. Sultan Qaboos Univ Med J2014; 14: e342-348. 30. Ahmed LA, Salem HA, Mawsouf MN, Attia AS, Agha AM. Cardioprotective effects of ozone oxidative preconditioning in an in vivo model of ischemia/reperfusion injury in rats. Scand J Clin Lab Invest2012; 72:345-354. 31. El-Sawalhi MM, Darwish HA, Mausouf MN, Shaheen AA. Modulation of age-related changes in oxidative stress markers and energy status in the rat heart and hippocampus: a significant role for ozone therapy. Cell Biochem Funct2013; 31:518-525. 32. Koca K, Yurttaş Y, Yıldız C, Caycı T, Uysal B, Korkmaz A. Effect of hyperbaric oxygen and ozone preconditioning on oxidative/nitrosative stress induced by tourniquet ischemia/reperfusion in rat skeletal muscle. Acta Orthop Traumatol Turc2010; 44:476-83. 33. Ozkan H, Ekinci S, Uysal B, Akyildiz F, Turkkan S, Ersen O, Koca K, Seven MM. Evaluation and comparison of the effect of hypothermia and ozone on ischemia-reperfusion injury of skeletal muscle in rats. J Surg Res2015; 196: 313-9. 34. Kesik V, Uysal B, Kurt B, Kismet E, Koseoglu V. Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biol Ther2009; 8:1623-1628. 35. Bakkal BH, Gultekin FA, Guven B, Turkcu UO, Bektas S, Can M. Effect of ozone oxidative preconditioning in preventing early radiation-induced lung injury in rats. Braz J Med Biol Res2013; 46:789-796. 36. Rodríguez ZZ, Guanche D, Alvarez RG, Rosales FH, Alonso Y, Schulz S. Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis. Inflamm Res2009; 58:371-375. 37. Alvarez RG, Zamora ZB, Borrego A, Delgado R, Schulz S, Alonso Y. Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: induced endotoxic shock in mice. Inflamm Res2009; 58: 441-443. 38. Hernández Rosales FA, Calunga Fernández JL, Turrent Figueras J, Menéndez Cepero S, Montenegro Perdomo A. Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res2005; 36: 549-554. 39. José Luis Calunga F, Yuleidys Paz A, Silvia Menéndez C, Alfredo Martínez, Aparicio Hernández. Rectal ozone therapy for patients with pulmonary emphysema. Rev Med Chile 2011; 139: 439-447. 40. Borrelli E and Bocci V. Oxygen ozone therapy in the treatment of chronic obstructive pulmonary disease: An integrative approach. American Journal of Clinical and Experimental Medicine 2014; 2:9-13. 41. Lin SY,Zhang SZ,An JX, Qian XY, Gao XY, Wang Y, Zhao WX, Eastwood D, Cope DK, Williams JP. The effect of ultrasound-guided percutaneous ozone injection around cervical dorsal root ganglion in zoster-associated pain: a retrospective study. J Pain Res. 2018; 11:2179-2188. 42. An JX,Liu H,Chen RW, Wang Y, Zhao WX, Eastwood D, Williams JP. Computed tomography-guided percutaneous ozone injection of the Gasserian ganglion for the treatment of trigeminal neuralgia. J Pain Res. 11: 255-263. 43. Wang Xilian, He Pingping, Zhou Zhongqun, Ouyang Xinping. Curative analysis of pregabalin combined with medical ozone in treating old patients with postherpetic neuralgia. J Mod Med Health. 2013; 10. 44. YANG Min. Clinical Observation on Efficacy of Ozone Combined with Epidural Anesthesia in Treatment of Herpes Zoster Neuralgia. J Xianning University. 2011; 2. 45. Lerong WANG; Zhonghui ZHANG. Therapeutic Observation of Acupuncture plus Ozone Injection for Neuralgia Due to Acute Herpes Zoster. Shanghai J of Acupuncture and Moxibustion. 2016;35: 527-529. 46. LIANG Dong, SHEN Wen, ZHANG Li-Cai Combination of selective never root block and intradermic ozone injection for the treatment of postherpetic neuralgia. Chinese J Pain. 2011; 4. 47. Linkai Jiang and Yimei Li. Clinical Observation of Treating PHN by Dorsal Root Ganglia Radio Frequency Combined Ozone. Journal of Medical Research2017; 46: 138-142. 48. Kumar T,Arora N,Puri G, Aravinda K, Dixit A, Jatti D. Efficacy of ozonized olive oil in the management of oral lesions and conditions: A clinical trial. Contemp Clin Dent. 2016; 7: 51-54. 49. Pereira J, Sargento P, Faria M, Teixeira M. Ozone Therapy for Herpes Zoster: case report. 2017. In Ribeiro, J. & Lima, E. (eds). Atas do II Encontro Nacional de Novos Investigadores em Saúde & II International Meeting of New Health. 50. Huang J,Huang J,Xiang Y, Gao L, Pan Y, Lu J. [Topical ozone therapy: An innovative solution to patients with herpes zoster]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018; 43: 168-172. 51. Bocci V. Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis. Med Hypotheses.1992; 39:30-34. 52. Mandzhgaladze NR,Kharebava ER,Didia TsG, Ardzhevanishvili MD, Gudzhabidze MV, Chigiashvili TsN. [Influence of intravenous ozone treatment on the level of different specificity antibodies]. Georgian Med News 2006; 138:93-5. 53. Heinz Konrad, M.D. Ozone therapy for post-herpetic neuralgia. A retrospective study of 55 cases. Largo Como 330, 04922-130 São Paulo, Brazil Fax: +55 11 55145138 e-mail: konrad@sti.com.br. 54. Hu B,Zheng J,Liu Q, Yang Y, Zhang Y. The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J Pain Res. 2018; 11:1637-1643. 55. Carpendale MT, Freeberg JK. Ozone inactivates HIV at noncytotoxic concentrations. Antiviral Res. 1991; 16:281-92. 56. Bocci. A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How ‘Inflammatory’ Cytokines may have A therapeutic Role. Mediators Inflamm. 1994; 3: 315–321. 57. Bocci V,Venturi G,Catucci M, Valensin PE, Zazzi M. Lack of efficacy of ozone therapy in HIV infection. Clin Microbiol Infect. 1998; 4:667-669. 58. Garber GE, Cameron DW, Hawley-Foss N, Greenway D, Shannon ME. The use of ozone-treated blood in the therapy of HIV infection and immune disease: a pilot study of safety and efficacy. 1991; 5:981-984. 59. Carpendale MT, Freeberg J, Griffiss JM. Does ozone alleviate AIDS diarrhea? J Clin Gastroenterol.1993; 17: 142-145. 60. Cespedes-Suarez J, Martin-Serrano Y, Carballosa-Peña MR, Dager- Carballosa DR. The immune response behavior in HIV-AIDS patients treated with Ozone therapy for two years. Journal of Ozone Therapy. 2018; 2: 1-9. 61. Neronov VA. [Experience with the use of ozone for the treatment of chronic viral hepatitis]. Vopr Kurortol Fizioter Lech Fiz Kult.2009; 6:14-17. 62. Chernyshev AL,Filimonov RM,Karasev AV, Neronov VA, Maksimov VA. [Combined treatment including ozonotherapy of patients with viral hepatitis]. Vopr Kurortol Fizioter Lech Fiz Kult. 2008; 3:19-22. 63. Jiao XJ, Peng X. [Clinilal study of medical ozone therapy in chronic hepatitis B of 20 patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi.2008; 22:484-485. 64. Zaky S, Kamel SE, Hassan MS, Sallam NA, Shahata MA, Helal SR, Mahmoud H. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. J Altern Complement Med. 2011; 17:259-263. 65. Gu XB, Yang XJ, Zhu HY, Xu YQ, Liu XY. Effect of medical ozone therapy on renal blood flow and renal function of patients with chronic severe hepatitis. Chin Med J (Engl).2010; 123: 2510-2513. 66. Cespedes-Suarez J, Martin-Serrano Y, Carballosa-Peña MR, Dager-Carballosa DR. Response of patients with chronic Hepatitis B in one year of treatment with Major Autohemotherapy. Journal of Ozone Therapy 2018; 2: 1-7. 67. Menéndez S and W Mark. Advances of Ozone Therapy in Medicine & Dentistry. Havanna University 2016. 68. Bocci V, and Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. 1990; Haematologica 75: 510–515. 69. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res.1993; 12:121-126. 70. J Biol Regul Homeost Agents.1998; 12:67-75. Studies on the biological effects ofozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R. 71. Larini A, Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol In Vitro.2005; 19: 55-61. 72. Diaz-Luis J, Menendez-Cepero S, Macias-Abraham C. Ozone Therapy Immunomodulatory Effect in the Selective Immunoglobulin A Deficiency. Journal of Ozone Therapy 2015; 1: 2-9. 73. Puga R., Rodrigues R., Gonzales C., Munoz J. Ozone Therapy In Treatment Of Patients With Secondary Immunodeficiencies. 2nd International Symposium on Ozone Applications, Havana, Cuba: p. 54-55 (1997), abstract. 74. Díaz LJ, Macías AC, Menéndez CS. Modulator effect of ozone therapy over immune system activity. Rev Cubana Hematol Inmunol Hemoter 2013; 29 (2).